Stay updated on OMS721 Compassionate Use in TMA Clinical Trial
Sign up to get notified when there's something new on the OMS721 Compassionate Use in TMA Clinical Trial page.

Latest updates to the OMS721 Compassionate Use in TMA Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRemoved the term 'Thrombotic thrombocytopenic purpura' from the page's related terms/keywords section.SummaryDifference0.1%

- Check17 days agoChange DetectedRevision note updated to v3.5.0, replacing v3.4.3.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedRevision history updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.1%

- Check53 days agoChange DetectedAdded Thrombotic thrombocytopenic purpura to the study keyword terms and updated the page revision from v3.4.1 to v3.4.2.SummaryDifference0.2%

- Check60 days agoChange DetectedRevision: v3.4.1 is now displayed, replacing the previous v3.4.0. The page content, including study details and eligibility criteria, remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check74 days agoChange DetectedThe changes include showing a glossary toggle, small capitalization tweaks to QC-related text (Last Update Submitted that Met QC Criteria and No FEAR Act Data), and a new page revision label (Revision: v3.4.0) replacing the previous version (v3.3.4).SummaryDifference0.3%

Stay in the know with updates to OMS721 Compassionate Use in TMA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the OMS721 Compassionate Use in TMA Clinical Trial page.